Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Oncology Letters|February 1, 2024
A pilot study on the safety and efficacy of neoadjuvant chemo‑adoptive immunotherapy for locally advanced rectal cancerYu Okazawa, Takashi Kamigaki, Kiichi Sugimoto, et al.
Surgical Endoscopy|December 1, 2021
Intraoperative pressure monitoring of the lower leg for preventing compression-related complications associated with the lithotomy positionRyuji Kajitani, Maiko Minami, Yuka Kubo, et al.
Scientific Reports|February 19, 2020
5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabineYoichiro Yoshida, Yasuhiro Hashimoto, Makoto Miyazaki, et al.
Anticancer Research|June 4, 2021
The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and BevacizumabHidekazu Kuramochi, Takeshi Yamada, Yoichiro Yoshida, et al.
Anticancer Research|July 3, 2017
Hepatectomy for Liver Metastases of Colorectal Cancer After Adoptive Chemoimmunotherapy Using Activated αβ T-cellsFuminori Ishii, Yoichiro Yoshida, Yasushi Yamauchi, et al.
Scientific Reports|June 25, 2021
Oncological evaluation in the perioperative period using cfDNA with BRAF V600E mutation in patients with colorectal cancerKeita Tanaka, Yoichiro Yoshida, Teppei Yamada, et al.
International Journal of Clinical Oncology|October 6, 2022
Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study)Hiroshi Matsuoka, Takeshi Yamada, Ryo Ohta, et al.
International Journal of Clinical Oncology|October 21, 2020
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 studyYoichiro Yoshida, Takeshi Yamada, Hirohiko Kamiyama, et al.
Medical Oncology (Northwood, London, England)|April 26, 2019
Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)Naoki Nagata, Hiromichi Maeda, Keiichiro Ishibashi, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|December 19, 2024
A novel scoring system for the prediction of disease severity in STEC-HUSEmi Ishibazawa, Tsunehisa Nagamori, Mio June Kurisawa, et al.
Pageof 9